Member Directory


drnatmilton's picture

Nathaniel Milton, PhD

Contact Information

Nathaniel Milton, PhD
United Kingdom

Professional Information



My research is focussed on Alzheimer’s Drug Discovery and compounds that modify amyloid fibril toxicity. I have discovered amyloid peptide interactions with the Kisspeptin, Kissorphin and Neuropeptide-FF peptides, which prevent the toxicity of the amyloid peptides in vitro. I discovered that endocannabinoids are neuroprotective against the Alzheimer’s Amyloid-beta peptide in vitro. I have characterized interactions between amyloid peptides and the enzymes Catalase and Cyclin-Dependent-Kinase-1.

Financial Disclosure

Member reports the following financial or other potential conflicts of interest:
[Last updated: Aug 4, 2014]

My research has previously been funded by Insight Biotechnology Ltd and I held an honorary position of Research Director with them (Sept 1996 - March 2004).

I am the Founder and Research Director of NeuroDelta Ltd since May 2003.

I am the named inventor on patent applications held by Roehampton University for Kissorphin peptides use in Alzheimer's Disease, Diabetes and Creutzfeldt-Jakob Disease.